At what enterprise value was EMERALD KALAMA CHEMICAL acquired in 2021?

During the acquisition of EMERALD KALAMA CHEMICAL by LANXESS in 2021, the company was valued at an estimated revenue multiple of below 5x. The transaction's Enterprise Value is estimated to be in the range of 1b - 4b EUR. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the AgriFood industry currently tracks an average EBITDA multiple of 10.8x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of EMERALD KALAMA CHEMICAL when it was acquired by LANXESS?

The estimated EV/EBITDA multiple for EMERALD KALAMA CHEMICAL is in the range of 10x - 18x. For comparison, the AgriFood sector currently shows an average EBITDA multiple of 10.8x. Join our community for free to access full valuation data and industry trends.

When was EMERALD KALAMA CHEMICAL acquired by LANXESS?

EMERALD KALAMA CHEMICAL was acquired by LANXESS in 2021.

What was the revenue of EMERALD KALAMA CHEMICAL at the time of the deal?

The revenue of EMERALD KALAMA CHEMICAL at the time of the deal is estimated to be in the range of 250M - 500M EUR. Register for free to access the full transaction report and exact valuation multiples.

What was the EBITDA of EMERALD KALAMA CHEMICAL during the acquisition?

EMERALD KALAMA CHEMICAL's EBITDA is estimated to be in the range of 50M - 100M EUR. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the EMERALD KALAMA CHEMICAL acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the EMERALD KALAMA CHEMICAL deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://revistacultivar-de.com/Nachrichten/Lanxess-unterzeichnet-Vereinbarung-zur-%C3%9Cbernahme-von-Emerald-Kalama-Chemical

← DATABASE

Home Database AgriFoodEMERALD KALAMA CHEMICAL

02/2021

EMERALD KALAMA CHEMICAL acquired by LANXESS

UNITED STATES Food Processing / Ingredients EV 1b - 4b EUR

Context

LANXESS AG has signed a binding agreement to acquire 100% of the shares of Emerald Kalama Chemical from the US private equity firm American Securities LLC. This acquisition is a major strategic step for LANXESS, significantly strengthening its "Consumer Protection" segment by adding a complementary portfolio of high-margin preservatives and animal hygiene products. The deal also expands LANXESS's footprint in North America, which accounts for nearly half of the target's sales. The transaction is fully financed through LANXESS's existing liquidity and is expected to generate significant annual synergies within three years of completion.

EMERALD KALAMA CHEMICAL, which reported an EBITDA margin of LOGIN in 2020, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN to the average currently observed in the AgriFood sector (10.8x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in AgriFood market trends

Target

Emerald Kalama Chemical is a world-leading manufacturer of specialty chemicals, with a specific focus on the consumer segment. The company is the global leader in benzoate chemistry (preservatives). Its portfolio is split into two main areas: Consumer Specialties (75% of sales), which includes preservatives for food, household, and cosmetic applications, as well as flavors, fragrances, and animal nutrition products

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2020

2019

Similar deals in AgriFood

List of similar M&A transactions (Date, Acquirer, Target, Country, Sector, Deal Context)
Date	Acquirer	Target	Country	Sector	Deal Context
04/2021	CREDIT MUTUEL EQUITY	CHARLES & ALICE	FRANCE	Food Processing	After 8 years under Equistone's control, the management team, led by Thierry Goubault, initiated a buyout alongside Credit Mutuel Equity. Management would then hold 40% of the capital, while the investment firm would acquire approximately 60%
03/2021	LIFEBRANDS NATURAL FOOD	REVOLUTION TEA	UNITED STATES	Food Processing	LIFEBRANDS Natural Food GmbH completed the acquisition of Revolution Tea, a US‑based specialty tea company, in March 2021, marking LIFEBRANDS’ entry into the US tea and hot‑beverage market. The transaction was structured as a full‑asset or 100% ownership takeover, with Revolution Tea retaining its brand identity, Phoenix‑area presence, and founding team leadership under a new group structure
12/2020	ERGON CAPITAL PARTNERS	MILLBO BIONATURALS GROUP	ITALY	Food Processing	Ergon Capital, a mid-market private equity firm, has acquired a majority stake in the Millbo-BioNaturals Group. This deal represents a strategic play within the high-growth natural food ingredients sector, aimed at transforming a family-owned technical leader into a global institutional platform
12/2020	CRONOS CAPITAL PARTNERS	EVERTON	ITALY	Food Processing	Cronos Capital Partners, alongside a group of private investors, acquired a majority stake in Everton, the Genoese tea, herbal‑infusion, and soluble‑preparation manufacturer, via a newly formed vehicle funded primarily through a substantial capital increase aimed at financing international growth and M&A activity
11/2020	PLATINUM EQUITY	BISCUIT INTERNATIONAL	FRANCE	Food Processing	Platinum Equity acquired a controlling stake in Biscuit International from its previous shareholders (Qualium Investissement). The transaction positions Platinum Equity to support the company's aggressive buy-and-build strategy in the fragmented European private label market
11/2020	RHONE CAPITAL	ILLYCAFFÈ	ITALY	Food Processing	Gruppo Illy sold a 20% minority stake in its operating company, Illycaffè SpA, to affiliates of Rhône Capital in a strategic transaction valued at around EUR 200 million. The deal was signed in November 2020 and closed in early 2021, marking the first time since the company’s founding in 1933 that Illycaffè opened its capital to a non‑family institutional investor
11/2020	AMSTERDAM COMMODITIES	SUNOPTA - GLOBAL INGREDIENTS BUSINESS	NETHERLANDS	Food Processing	Amsterdam Commodities N.V. (Acomo) has acquired the Global Ingredients business of SunOpta Inc. in a debt-free, cash-free transaction. This transformative acquisition adds Tradin Organic, a global leader in organic ingredients, to Acomo's existing portfolio of conventional commodities (spices, tea, seeds)
10/2020	HAUDECOEUR	PALAIS IMPÉRIAL	FRANCE	Food Processing	Haudecoeur, backed by Ergon Capital Partners and the founding family, completed the acquisition of Palais Impérial from its founders, Nicolas Pacheny and Arnaud Gillier, who reinvest alongside existing shareholders
08/2020	GLANDIA NUTRITIONALS	FOODAROM	CANADA	Food Processing	Glanbia Nutritionals has acquired the Canadian flavor designer Foodarom for CAD $60 million (~USD $45 million). This acquisition aligns with Glanbia's strategy to grow its "Nutritional Solutions" (NS) division by adding complementary capabilities
06/2020	ROYAL DSM	ERBER GROUP	AUSTRIA	Food Processing	Royal DSM has reached an agreement to acquire the Erber Group, specifically its specialty animal nutrition and health businesses, Biomin and Romer Labs. Two smaller units of the Erber Group (Sanphar and EFB, representing 7% of sales) are excluded from the transaction

REFERENCES

Valuation range: EV 1b - 4b EUR

Revenue range: 250M - 500M EUR

EBITDA range: 50M - 100M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of EMERALD KALAMA CHEMICAL by LANXESS are reserved for mynth community members. Register for free to unlock full data.

Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).